2018 Korean clinical imaging guideline for hemoptysis

Mi Jin Kang, Jin Hwan Kim, Yoon Kyung Kim, Hyun Joo Lee, Kyung Min Shin, Jung Im Kim, Hyun Ju Lee, Kyung Hyun Do, Hwan-Seok Yong, Sol Ji Choi, Miyoung Choi, Jung Im Jung

Research output: Contribution to journalReview article

Abstract

In 2014, the American College of Radiology (ACR) announced the guideline for the appropriate diagnostic approach and treatment of patients according to the severity of hemoptysis and risk for lung cancer. However, the application of the ACR guideline in Korea may not be appropriate, because many patients in Korea have active tuberculosis or pulmonary fibrosis due to previous tuberculosis. The Korean Society of Radiology and Korean Society of Thoracic Radiology have proposed a new guideline suitable for Korean practice. This new guideline was prepared through the consensus of a development committee, working party, and an advisory committee. The guideline proposal process was based on an evidence-based clinical imaging guideline proposed by the development committee. Clinical imaging guideline for adult patients with hemoptysis is as follows: Chest radiography is an initial imaging modality to evaluate hemoptysis. Contrast-enhanced chest CT is recommended in patients with two risk factors for lung cancer (> 40 years old and > 30 pack-year smoking history), moderate hemoptysis (> 30 mL/24 hours) or recurrent hemoptysis. Contrast-enhanced chest CT is also recommended in patients with massive hemoptysis (> 400 mL/24 hours) without cardiopulmonary compromise.

Original languageEnglish
Pages (from-to)866-871
Number of pages6
JournalKorean Journal of Radiology
Volume19
Issue number5
DOIs
Publication statusPublished - 2018 Sep 1

Fingerprint

Hemoptysis
Guidelines
Radiology
Thorax
Korea
Lung Neoplasms
Tuberculosis
Pulmonary Fibrosis
Advisory Committees
Radiography
Consensus
Smoking
History

Keywords

  • Computed tomography
  • Evidence
  • Guideline
  • Hemoptysis
  • Lung
  • Radiography
  • Republic of korea
  • Thorax
  • X-ray

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Kang, M. J., Kim, J. H., Kim, Y. K., Lee, H. J., Shin, K. M., Kim, J. I., ... Jung, J. I. (2018). 2018 Korean clinical imaging guideline for hemoptysis. Korean Journal of Radiology, 19(5), 866-871. https://doi.org/10.3348/kjr.2018.19.5.866

2018 Korean clinical imaging guideline for hemoptysis. / Kang, Mi Jin; Kim, Jin Hwan; Kim, Yoon Kyung; Lee, Hyun Joo; Shin, Kyung Min; Kim, Jung Im; Lee, Hyun Ju; Do, Kyung Hyun; Yong, Hwan-Seok; Choi, Sol Ji; Choi, Miyoung; Jung, Jung Im.

In: Korean Journal of Radiology, Vol. 19, No. 5, 01.09.2018, p. 866-871.

Research output: Contribution to journalReview article

Kang, MJ, Kim, JH, Kim, YK, Lee, HJ, Shin, KM, Kim, JI, Lee, HJ, Do, KH, Yong, H-S, Choi, SJ, Choi, M & Jung, JI 2018, '2018 Korean clinical imaging guideline for hemoptysis', Korean Journal of Radiology, vol. 19, no. 5, pp. 866-871. https://doi.org/10.3348/kjr.2018.19.5.866
Kang MJ, Kim JH, Kim YK, Lee HJ, Shin KM, Kim JI et al. 2018 Korean clinical imaging guideline for hemoptysis. Korean Journal of Radiology. 2018 Sep 1;19(5):866-871. https://doi.org/10.3348/kjr.2018.19.5.866
Kang, Mi Jin ; Kim, Jin Hwan ; Kim, Yoon Kyung ; Lee, Hyun Joo ; Shin, Kyung Min ; Kim, Jung Im ; Lee, Hyun Ju ; Do, Kyung Hyun ; Yong, Hwan-Seok ; Choi, Sol Ji ; Choi, Miyoung ; Jung, Jung Im. / 2018 Korean clinical imaging guideline for hemoptysis. In: Korean Journal of Radiology. 2018 ; Vol. 19, No. 5. pp. 866-871.
@article{7c4621087a2b4d2998c158f7595c9c9d,
title = "2018 Korean clinical imaging guideline for hemoptysis",
abstract = "In 2014, the American College of Radiology (ACR) announced the guideline for the appropriate diagnostic approach and treatment of patients according to the severity of hemoptysis and risk for lung cancer. However, the application of the ACR guideline in Korea may not be appropriate, because many patients in Korea have active tuberculosis or pulmonary fibrosis due to previous tuberculosis. The Korean Society of Radiology and Korean Society of Thoracic Radiology have proposed a new guideline suitable for Korean practice. This new guideline was prepared through the consensus of a development committee, working party, and an advisory committee. The guideline proposal process was based on an evidence-based clinical imaging guideline proposed by the development committee. Clinical imaging guideline for adult patients with hemoptysis is as follows: Chest radiography is an initial imaging modality to evaluate hemoptysis. Contrast-enhanced chest CT is recommended in patients with two risk factors for lung cancer (> 40 years old and > 30 pack-year smoking history), moderate hemoptysis (> 30 mL/24 hours) or recurrent hemoptysis. Contrast-enhanced chest CT is also recommended in patients with massive hemoptysis (> 400 mL/24 hours) without cardiopulmonary compromise.",
keywords = "Computed tomography, Evidence, Guideline, Hemoptysis, Lung, Radiography, Republic of korea, Thorax, X-ray",
author = "Kang, {Mi Jin} and Kim, {Jin Hwan} and Kim, {Yoon Kyung} and Lee, {Hyun Joo} and Shin, {Kyung Min} and Kim, {Jung Im} and Lee, {Hyun Ju} and Do, {Kyung Hyun} and Hwan-Seok Yong and Choi, {Sol Ji} and Miyoung Choi and Jung, {Jung Im}",
year = "2018",
month = "9",
day = "1",
doi = "10.3348/kjr.2018.19.5.866",
language = "English",
volume = "19",
pages = "866--871",
journal = "Korean Journal of Radiology",
issn = "1229-6929",
publisher = "Korean Radiological Society",
number = "5",

}

TY - JOUR

T1 - 2018 Korean clinical imaging guideline for hemoptysis

AU - Kang, Mi Jin

AU - Kim, Jin Hwan

AU - Kim, Yoon Kyung

AU - Lee, Hyun Joo

AU - Shin, Kyung Min

AU - Kim, Jung Im

AU - Lee, Hyun Ju

AU - Do, Kyung Hyun

AU - Yong, Hwan-Seok

AU - Choi, Sol Ji

AU - Choi, Miyoung

AU - Jung, Jung Im

PY - 2018/9/1

Y1 - 2018/9/1

N2 - In 2014, the American College of Radiology (ACR) announced the guideline for the appropriate diagnostic approach and treatment of patients according to the severity of hemoptysis and risk for lung cancer. However, the application of the ACR guideline in Korea may not be appropriate, because many patients in Korea have active tuberculosis or pulmonary fibrosis due to previous tuberculosis. The Korean Society of Radiology and Korean Society of Thoracic Radiology have proposed a new guideline suitable for Korean practice. This new guideline was prepared through the consensus of a development committee, working party, and an advisory committee. The guideline proposal process was based on an evidence-based clinical imaging guideline proposed by the development committee. Clinical imaging guideline for adult patients with hemoptysis is as follows: Chest radiography is an initial imaging modality to evaluate hemoptysis. Contrast-enhanced chest CT is recommended in patients with two risk factors for lung cancer (> 40 years old and > 30 pack-year smoking history), moderate hemoptysis (> 30 mL/24 hours) or recurrent hemoptysis. Contrast-enhanced chest CT is also recommended in patients with massive hemoptysis (> 400 mL/24 hours) without cardiopulmonary compromise.

AB - In 2014, the American College of Radiology (ACR) announced the guideline for the appropriate diagnostic approach and treatment of patients according to the severity of hemoptysis and risk for lung cancer. However, the application of the ACR guideline in Korea may not be appropriate, because many patients in Korea have active tuberculosis or pulmonary fibrosis due to previous tuberculosis. The Korean Society of Radiology and Korean Society of Thoracic Radiology have proposed a new guideline suitable for Korean practice. This new guideline was prepared through the consensus of a development committee, working party, and an advisory committee. The guideline proposal process was based on an evidence-based clinical imaging guideline proposed by the development committee. Clinical imaging guideline for adult patients with hemoptysis is as follows: Chest radiography is an initial imaging modality to evaluate hemoptysis. Contrast-enhanced chest CT is recommended in patients with two risk factors for lung cancer (> 40 years old and > 30 pack-year smoking history), moderate hemoptysis (> 30 mL/24 hours) or recurrent hemoptysis. Contrast-enhanced chest CT is also recommended in patients with massive hemoptysis (> 400 mL/24 hours) without cardiopulmonary compromise.

KW - Computed tomography

KW - Evidence

KW - Guideline

KW - Hemoptysis

KW - Lung

KW - Radiography

KW - Republic of korea

KW - Thorax

KW - X-ray

UR - http://www.scopus.com/inward/record.url?scp=85051397105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051397105&partnerID=8YFLogxK

U2 - 10.3348/kjr.2018.19.5.866

DO - 10.3348/kjr.2018.19.5.866

M3 - Review article

VL - 19

SP - 866

EP - 871

JO - Korean Journal of Radiology

JF - Korean Journal of Radiology

SN - 1229-6929

IS - 5

ER -